Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US-December 14, 2020-January 18, 2021.

Shimabukuro, Tom T; Cole, Matthew; Su, John R

Shimabukuro, Tom T; Cole, Matthew; Su, John R.

Shimabukuro TT; Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Cole M; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Su JR; Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.

JAMA ; 325(11): 1101-1102, 2021 Mar 16.

Article in English | MEDLINE | ID: covidwho-1168761

Subject(s)

Anaphylaxis/etiology; COVID-19 Vaccines/adverse effects; Adult; Adverse Drug Reaction Reporting Systems; Anaphylaxis/epidemiology; Female; Hospitalization/statistics & numerical data; Humans; Male; Middle Aged; United States/epidemiology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / Anaphylaxis Type of study: Observational study Topics: Vaccines Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: North America Language: English Journal: JAMA Year: 2021 Document Type: Article Affiliation country: Jama.2021.1967

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google